Charles Drew University of Medicine and Science
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Charles Drew University of Medicine and Science sits in the top decile of US sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count).
Charles Drew University of Medicine and Science: 30 sponsored US clinical trials, 1 recruiting.
Charles Drew University of Medicine and Science sponsors 30 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 20 completed. 6 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Infections, with 2 trials.
Top-decile sponsor footprint
Charles Drew University of Medicine and Science ranks in the top decile of sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
20 of 25 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
30 total, page 1 of 1
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
NCT06615752
Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes
NCT05765214
Entre Herman@s: Promoting Health Among Latino MSM
NCT05805306
Obesity Group Visits. A Novel Way to Approach the Obesity Epidemic in an Inner-City Setting
NCT04725058
Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images
NCT03694145
ACTIVATE in Public Housing
NCT06075732
Increasing Vaccine Uptake in Underresourced Public Housing Areas
NCT04779138
COVID-19 Risk Reduction Among African American Parishioners
NCT04542343
Cancer Leadership Training for Clergy Wives and Widows
NCT04544241
Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus
NCT03052400
Reducing HIV Risk With High Risk HIV Negative Black MSM-Passport to Wellness
NCT02932384
Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus
NCT02303405
To Study the Nutri-Genomic Response of Vit-D Supplementation in African-Americans
NCT02802449
Females of African American Legacy Empowering Self (FemAALES)
NCT02189876
The Effects of a Glutathione Precursor (FT061452),on Serum and Intracellular Glutathione Levels
NCT01251315
Vitamin D in Minorities With Prediabetes
NCT00876928
Dance Dance Revolution (DDR) in Type 2 Diabetes
NCT00851019
Insulin Resistance in Smokers Undergoing Smoking Cessation
NCT00877513
Sitagliptin in Combination With Metformin and Sulfonylurea
NCT00686634
Delivery of Soluble Ferric Pyrophosphate (SFP) Via the Dialysate to Maintain Iron Balance in Hemodialysis Patients
NCT00604565
Men of African American Legacy Empowering Self
NCT01492530
Testosterone Replacement in Postmenopausal Women With Stress Urinary Incontinence
NCT03116087
Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.
NCT00624013
Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria
NCT00907374
Exercise Dose-Response on Features of the Metabolic Syndrome
NCT00687128
Testosterone Gel Applied to Women With Pituitary Gland Problems
NCT00144391
Insulin Glargine at Bedtime or in AM Versus NPH
NCT00686712
Insulin Glargine Versus Twice-Daily NPH
NCT00687453
Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS
NCT00598585
Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women
NCT00004400
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 4 |
| Phase 4 | 6 |
What is open in the Charles Drew University of Medicine and Science pipeline
1 recruiting of 30 indexed (3% open); 20 completed (67%).
Phase mix: 6 late (III/IV) vs 6 early (I/II) (balanced across stages).
Top condition: HIV Infections (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Charles Drew University of Medicine and Science: open-pipeline peers nationwide
Peers matched on 30 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Charles Drew University of Medicine and Science sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 30 trials (± recruiting share)
- Biotronik · 30 trials · 3% recruiting
- Chiesi Farmaceutici S.p.A. · 30 trials · 13% recruiting
- Debiopharm International · 30 trials · 17% recruiting
- Exact Sciences Corporation · 30 trials · 10% recruiting
Sponsors near 3% open enrollment (± trial volume)
- Kyntra Bio · 3% recruiting · 30 trials
- New York State Psychiatric Institute · 3% recruiting · 364 trials
- Wills Eye · 3% recruiting · 59 trials
- SCRI Development Innovations · 3% recruiting · 146 trials
Related
What to do with this Charles Drew University of Medicine and Science page
30 registered trials is a research-attention snapshot, not an endorsement of Charles Drew University of Medicine and Science or any single study.
- 1 of Charles Drew University of Medicine and Science's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- HIV Infections is the condition Charles Drew University of Medicine and Science studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Infections trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Charles Drew University of Medicine and Science pipeline card: 30 registered trials from official public datasets.Report a data error.